118 related articles for article (PubMed ID: 10958939)
21. Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.
Rondón-Lagos M; Verdun Di Cantogno L; Rangel N; Mele T; Ramírez-Clavijo SR; Scagliotti G; Marchiò C; Sapino A
BMC Cancer; 2014 Dec; 14():922. PubMed ID: 25481507
[TBL] [Abstract][Full Text] [Related]
22. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
23. Aberrations of chromosomes 1 and 17 in six human osteosarcoma cell lines using double-target fluorescence in situ hybridization.
Murata H; Kusuzaki K; Takeshita H; Hirasawa Y; Ashihara T; Abe T; Inazawa J
Cancer Genet Cytogenet; 1998 Nov; 107(1):7-10. PubMed ID: 9809027
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
[TBL] [Abstract][Full Text] [Related]
25. Numerical aberrations of chromosomes 1 and 17 in tumor cell lines of the exocrine pancreas as determined by fluorescence in situ hybridization.
Verdoodt B; Charlette I; Maillet B; Kirsch-Volders M
Cancer Genet Cytogenet; 1997 Apr; 94(2):125-30. PubMed ID: 9109941
[TBL] [Abstract][Full Text] [Related]
26. Gene or genome? The meaning of gains/losses of chromosome.
Itoh F; Imai K
J Gastroenterol; 1999 Feb; 34(1):147-8. PubMed ID: 10204628
[No Abstract] [Full Text] [Related]
27. Chromosome 9 and 17 aberrations and p53 gene deletion detected by fluorescence in situ hybridization in renal-cell carcinoma.
Yoshioka K; Nakamura S
Mol Urol; 2001; 5(1):11-7. PubMed ID: 11689146
[TBL] [Abstract][Full Text] [Related]
28. Numerical aberrations of chromosome 17 and the p53 locus in small hepatocellular carcinomas.
Yano H; Nanashima A; Hidaka S; Haseba M; Tanaka K; Yamaguchi H; Nakagoe T; Tagawa Y; Nagayasu T
Anticancer Res; 2004; 24(1):111-5. PubMed ID: 15015584
[TBL] [Abstract][Full Text] [Related]
29. Numerical aberrations of chromosome 17 detected by FISH with DNA-specific probe in oral tumors.
Tsuji T; Mimura Y; Maeda K; Ida M; Sasaki K; Shinozaki F
Anticancer Res; 1994; 14(5A):1689-93. PubMed ID: 7847802
[TBL] [Abstract][Full Text] [Related]
30. Detection of cellular heterogeneity by DNA ploidy, 17 chromosome, and p53 gene in primary carcinoma and metastasis in a case of ovarian cancer.
Calugi A; Eleuteri P; Cavallo D; Naso G; Albonici L; Lombardi MP; Manzari V; Romanini C; DeVita R
Int J Gynecol Pathol; 1996 Jan; 15(1):77-81. PubMed ID: 8852451
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
[TBL] [Abstract][Full Text] [Related]
32. Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
Stadler WM; Steinberg G; Yang X; Hagos F; Turner C; Olopade OI
Clin Cancer Res; 2001 Jun; 7(6):1676-82. PubMed ID: 11410506
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
[TBL] [Abstract][Full Text] [Related]
34. Deletions of 17p are associated with transition from early to advanced colorectal cancer.
Risio M; Casorzo L; Chiecchio L; De Rosa G; Rossini FP
Cancer Genet Cytogenet; 2003 Nov; 147(1):44-9. PubMed ID: 14580770
[TBL] [Abstract][Full Text] [Related]
35. Instability of chromosome 17 and the p53 locus in non-familial colorectal cancer with multiple primary malignancies.
Sawai T; Nanashima A; Tsuji T; Yamaguchi H; Yasutake T; Nakagoe T; Ayabe H; Tagawa Y
J Exp Clin Cancer Res; 2001 Sep; 20(3):401-5. PubMed ID: 11718221
[TBL] [Abstract][Full Text] [Related]
36. [p53 alterations and chromosome 17 aberrations in non-small cell lung cancer].
Tsuji T; Tagawa Y; Hisamatsu T; Nakamura S; Terada R; Sawai T; Yasutake T; Ayabe H
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():263-8. PubMed ID: 9263513
[TBL] [Abstract][Full Text] [Related]
37. Quick-FISH: a rapid fluorescence in situ hybridization technique for molecular cytogenetic analysis.
Banerjee SK; Weston AP; Persons DL; Campbell DR
Biotechniques; 1998 May; 24(5):826-30. PubMed ID: 9591133
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of relationship between chromosome 22 and p53 gene alterations and the subtype of meningiomas by the interphase-FISH technique.
Yakut T; Bekar A; Doygun M; Acar H; Egeli U; Ogul E
Teratog Carcinog Mutagen; 2002; 22(3):217-25. PubMed ID: 11948632
[TBL] [Abstract][Full Text] [Related]
39. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
[TBL] [Abstract][Full Text] [Related]
40. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
